Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Kirkland’s EIT Pharma Shares Milestone for Drug Treating Chronic Hepatitis D

Summary by 425 Magazine
If ultimately approved by the FDA, Lonafarnib’s oral administration, room-temperature storage, and potential for long-term survival may offer practical advantages for people with CHD and for healthcare providers.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

425 Magazine425 Magazine

Kirkland’s EIT Pharma Shares Milestone for Drug Treating Chronic Hepatitis D

If ultimately approved by the FDA, Lonafarnib’s oral administration, room-temperature storage, and potential for long-term survival may offer practical advantages for people with CHD and for healthcare providers.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

425 Magazine broke the news on Thursday, August 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Kirkland, Washington icon

Kirkland, Washington

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal